Analytic Investors’s Xylem XYL Stock Holding History

Analytic Investors’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-110,839	Closed	-$4.53M	–	678
2016 Q1	$4.53M	Buy	+110,839	New	+$4.08M	0.06%	210

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Analytic Investors's XYL Position: Q2 2016 in Review

Analytic Investors sold out of Xylem (XYL) in Q2 2016, closing a stake of 110,839 shares — an estimated $4.53M sold.

Analytic Investors first reported a position in XYL in Q1 2016 and held it in 1 quarter. The position peaked at $4.53M in Q1 2016. 523 funds tracked by Wall St. Rank hold XYL as of Q2 2016.

Analytic Investors reported no remaining Xylem position as of Q2 2016 after selling out during the quarter.
Analytic Investors sold 110,839 Xylem shares in Q2 2016, an estimated $4.53M.
Analytic Investors first reported a position in Xylem in Q1 2016 and held it in 1 quarter.
Analytic Investors's Xylem position peaked at $4.53M in Q1 2016.
523 funds tracked by Wall St. Rank held Xylem as of Q2 2016.

Based on Analytic Investors's 13F filing for Q2 2016, filed 11 Aug 2016.